Clinical trials
Phase 3 Fallopian Tube Neoplasms trials in Denmark
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
15 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2005 | 1 |
| 2009 | 2 |
| 2011 | 2 |
| 2012 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2021 | 1 |
| 2025 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 8 |
| Active, not recruiting | 3 |
| Recruiting | 2 |
| Terminated | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AGO Study Group | 2 |
| Amgen | 2 |
| Merck Sharp & Dohme LLC | 2 |
| Novartis Pharmaceuticals | 2 |
| Eli Lilly and Company | 1 |
| European Organisation for Research and Treatment of Cancer - EORTC | 1 |
| Genmab | 1 |
| Hoffmann-La Roche | 1 |
| Nordic Society of Gynaecological Oncology - Clinical Trials Unit | 1 |
| Oasmia Pharmaceutical AB | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fallopian Tube Neoplasms | 15 |
| Ovarian Neoplasms | 14 |
| Carcinoma, Ovarian Epithelial | 8 |
| Peritoneal Neoplasms | 4 |
| Neoplasms | 2 |
| Genital Diseases, Female | 1 |
| Neoplasm Metastasis | 1 |
| Ovarian Diseases | 1 |
| Pathologic Complete Response | 1 |
| Recurrence | 1 |
Trials
Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.